Suchergebnisse - "Jo, Tatsuro"

PubPharm (59)

1

An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)

enthalten in: Future oncology (London, England) | 2024

von Abe, Y. | Kubonishi, S. | Ri, M. | +16

2

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Jo, T. | Kubota-Koketsu, R. | Kaneko, Y. | +7

3

Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia-lymphoma

enthalten in: Haematologica | 2023

von Hiramatsu, H. | Nosaka, K. | Kusumoto, S. | +23

4

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

enthalten in: Genes & cancer | 2023

von Jo, T.

5

HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia/lymphoma

enthalten in: Cancer medicine | 2022

von Jo, T. | Noguchi, K. | Sakai, T. | +6

6

Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma : Phase IIb results

enthalten in: Cancer science | 2022

von Utsunomiya, A. | Izutsu, K. | Jo, T. | +21

7

Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab

enthalten in: British journal of haematology | 2022

von Nosaka, K. | Kusumoto, S. | Nakano, N. | +21

8

Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab

enthalten in: British Journal of Haematology | 2022

von Nosaka, K. | Kusumoto, S. | Nakano, N. | +21

9

HTLV‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma

enthalten in: Cancer Medicine | 2022

von Jo, T. | Noguchi, K. | Sakai, T. | +6

10

Oral histone deacetylase inhibitor tucidinostat ( HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma : Phase IIb results

enthalten in: Cancer Science | 2022

von Utsunomiya, A. | Izutsu, K. | Jo, T. | +21

1
2
3
4
5
6
Nächster »
[6]